# Tengyuan Capital

Tengyuan Capital is a Private Equity based in Shanghai, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Shanghai, China
- **Region:** Asia
- **Address:** Shanghai, China
- **Assets under management:** Undisclosed
- **Website:** https://tengyuan.com

## Regulatory record

- **Reports private funds:** No

## About

Tengyuan Capital is an investment fund focused on health care, pharmaceuticals, and other large health sectors. It has made two investments, including a Seed VC in Affinity on July 16, 2019. The fund has one portfolio exit, TYK Medicines, which occurred on August 20, 2024.

## Questions

### Who runs investment decisions at Tengyuan Capital?

No principals are publicly named, and the firm does not maintain a website or LinkedIn presence. Decision-making authority cannot be independently verified without direct access to the firm.

### What is Tengyuan Capital's known AUM or deployment scale?

Tengyuan Capital has not publicly disclosed assets under management or cumulative deployment. The firm operates without the institutional disclosures typical of branded Chinese VC platforms, making external sizing impossible.

### What investment stages does Tengyuan Capital target?

Per Altss research, Tengyuan's strategy covers early-stage investments, including seed, start-up, and general venture rounds. No specific stage concentration or check-size range has been publicly disclosed.

## Related profiles

- [Tenfore Holdings](https://altss.com/profile/tenfore-holdings)
- [Terre & Fils Investissement](https://altss.com/profile/terre-and-fils-investissement)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/tengyuan-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology